Evidence map›Paper›PMID 39052940›Full record

ArticleBioinformatics (Oxford, England)2024

TSpred: a robust prediction framework for TCR-epitope interactions using paired chain TCR sequence data.

Ha Young Kim, Sungsik Kim, Woong-Yang Park, Dongsup Kim

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ha Young KimDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, South Korea.
Sungsik KimGENINUS Inc., Seoul 05836, South Korea.
Woong-Yang ParkGENINUS Inc., Seoul 05836, South Korea.
Dongsup KimDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, South Korea.ORCID 0000-0002-5916-6799

Funding

National Research Foundation of Korea RS-2024-00344154
6 · The paper itself

Abstract

motivationPrediction of T-cell receptor (TCR)-epitope interactions is important for many applications in biomedical research, such as cancer immunotherapy and vaccine design. The prediction of TCR-epitope interactions remains challenging especially for novel epitopes, due to the scarcity of available data.

resultsWe propose TSpred, a new deep learning approach for the pan-specific prediction of TCR binding specificity based on paired chain TCR data. We develop a robust model that generalizes well to unseen epitopes by combining the predictive power of CNN and the attention mechanism. In particular, we design a reciprocal attention mechanism which focuses on extracting the patterns underlying TCR-epitope interactions. Upon a comprehensive evaluation of our model, we find that TSpred achieves state-of-the-art performances in both seen and unseen epitope specificity prediction tasks. Also, compared to other predictors, TSpred is more robust to bias related to peptide imbalance in the dataset. In addition, the reciprocal attention component of our model allows for model interpretability by capturing structurally important binding regions. Results indicate that TSpred is a robust and reliable method for the task of TCR-epitope binding prediction. AVAILABILITY AND IMPLEMENTATION: Source code is available at https://github.com/ha01994/TSpred.

Indexed as

Receptors, Antigen, T-CellComputational BiologyDeep LearningEpitopes, T-LymphocyteHumansProtein BindingSoftwareEpitopes, T-LymphocyteReceptors, Antigen, T-Cell

Identifiers

PMID39052940
PMCPMC11297499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.